Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Portland, OR
NPI
1487709259
Since 2007
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3181 SW Sam Jackson Park Rd, Cdrc-P
Portland, OR, 97239
Phone (503) 494-2370
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
35 prescriptions
Company payments, 2025
$35K
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Erika L Finanger prescribed most often to Medicare patients was Exondys-51 (Eteplirsen), with 18 prescriptions and refills. In total Erika L Finanger wrote 35 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Exondys-51 Eteplirsen | 18 | 18 | Under 11 | $1.6M |
| Emflaza Deflazacort | 13 | 13 | Under 11 | $154K |
Brand drugs: 31 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erika L Finanger $35K ($35K in general payments such as food, travel and fees) from 6 companies. The largest payer was Sarepta Therapeutics, Inc. with $26K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.